Chemoenzymatic synthesis of peptide beta-lactones and beta-hydroxy acids

Patent metadata

Field	Value
Publication number	US-10655153-B2
Application number	US-201815921442-A
Country	US
Kind code	B2
Filing date	Mar 14, 2018
Priority date	Mar 14, 2017
Publication date	May 19, 2020
Grant date	May 19, 2020

Abstract

Methods of producing peptide beta-lactones and beta-hydroxy acids are disclosed that include contacting a beta-hydroxy-alpha-amino acid, an aryl carrier protein (ObiD), and ATP with a non-ribosomal protein synthetase. A continuous flow reactor is disclosed that includes an elongate conduit with at least one region that includes a first region with a non-ribosomal protein synthetase immobilized to a substrate. The non-ribosomal protein synthetase of the continuous flow reactor is configured to contact a flow of a reaction mixture that includes a beta-hydroxy-alpha-amino acid and an aryl carrier protein. The non-ribosomal protein synthetase is further configured to release a peptide beta-lactone into the flow of the reaction mixture.

First claim

What is claimed is:

1. A method of producing a peptide beta-lactone, the method comprising contacting a beta-hydroxy-alpha-amino acid, a benzoic acid derivative, an aryl carrier protein, and ATP with a non-ribosomal protein synthetase, wherein:
the beta-hydroxy-alpha-amino acid is selected from the group consisting of beta-OH-p-NO 2 -homoPhe and beta-OH-homoPhe;
the aryl carrier protein comprises the amino acid sequence of SEQ ID NO:1;
the non-ribosomal protein synthetase comprises the amino acid sequence of any one of SEQ ID NOS:2, 25, and 26; and
the benzoic acid derivative is 2,3-dihydroxoybenzoic acid.

2. The method of claim 1 , wherein the peptide beta-lactone is selected from the group consisting of an obafluorin and an obafluorin analog, the obafluorin analog comprising a compound with the structure:

wherein n=0, 1, or 2; and
R=

3. The method of claim 1 , further comprising forming the beta-hydroxy-alpha-amino acid by contacting an aliphatic or aryl aldehyde or derivative thereof, an amino acid, and a pyridoxyl phosphate (PLP) cofactor with a serine hydroxymethyltransferase/threonine aldoloase, wherein:
the aliphatic or aryl aldehyde or derivative thereof is selected from the group consisting of aliphatic aldehydes, aromatic benzaldehydes, aromatic phenylacetaldehydes, and aromatic cinnamaldehydes;
the amino acid is selected from the group consisting of threonine, serine, glycine, and any isomer thereof; and
the serine hydroxymethyltransferase/threonine aldoloase comprises the amino acid sequence of SEQ ID NO:3.

4. The method of claim 3 , further comprising forming the aliphatic or aryl aldehyde or derivative thereof by contacting an aliphatic or aryl pyruvate or derivative thereof and thiamine pyrophosphate (TPP) with a thiamine dependent pyruvate decarboxylase, wherein: the phenyl pyruvate or derivative thereof is selected from the group consisting of: p-nitrophenylpyruvate, p-hydroxyphenylpyruvate, and phenylpyruvate; and
the thiamine dependent pyruvate decarboxylase comprises the amino acid sequence of SEQ ID NO:4.

5. The method of claim 4 , further comprising forming the aliphatic or aryl pyruvate derivative consisting of p-nitrophenylpyruvate by contacting p-aminophenylpyruvate, oxygen, and Fe(II) with a p-aminobenzoate N-oxygenase, wherein the p-aminobenzoate N-oxygenase comprises the amino acid sequence of SEQ ID NO:5.

6. The method of claim 1 , further comprising hydrolyzing the peptide beta-lactone to form a beta-hydroxy-acid, the beta-hydroxy-acid comprising a compound with any one of the structures given by:

wherein n=0, 1, 2; and
R=

7. A method of producing a peptide beta-lactone, the method comprising:
forming a reaction mixture comprising:
a beta-hydroxy-alpha-amino acid selected from the group consisting of beta-OH-p-NO 2 -homoPhe and beta-OH-homoPhe;
a benzoic acid derivative consisting of 2,3-dihydroxoybenzoic acid;
ATP;
an aryl carrier protein comprising the amino acid sequence of SEQ ID NO:1; and
a non-ribosomal protein synthetase comprising the amino acid sequence of any one of SEQ ID NOS:2, 25, and 26, the non-ribosomal protein synthetase further comprising a condensation domain (C), a first adenylation domain (A 1 ), a peptidyl carrier domain (PCP), a thioesterase domain (TE), and a second adenylation domain (A 2 );

contacting the beta-hydroxy-alpha-amino acid with the non-ribosomal protein synthetase at the peptidyl carrier domain (PCP) with ATP activation by the first adenylation domain (A 1 ) to form a PCP-beta-hydroxy-alpha-amino acid thioester comprising an alpha-amino moiety;
ATP-activating the benzoic acid derivative at the second adenylation domain (A 2 ) and contacting the ATP-activated benzoic acid derivative with the aryl carrier protein to form a benzoic acid derivative-aryl carrier protein thioester comprising a carbonyl moiety;
contacting the benzoic acid derivative-aryl carrier protein thioester with the condensation domain (C) to catalyze an amide bond between the alpha-amino moiety and the carbonyl moiety to form a PCP-peptide beta-lactone precursor thioester;
contacting the PCP-peptide beta-lactone precursor thioester with the thioesterase domain (TE) to form a transthioesterified peptide beta-lactone precursor; and
releasing the transthioesterified peptide beta-lactone precursor as a peptide beta-lactone from the non-ribosomal protein synthetase.

8. The method of claim 7 , wherein the method further comprises contacting the aryl carrier protein with a phosphopantetheinyl transferase (Sfp) enzyme.

9. The method of claim 7 , wherein the method further comprises contacting the non-ribosomal protein synthetase with a phosphopantetheinyl transferase (Sfp) enzyme.

10. The method of claim 7 , wherein the peptide beta-lactone is selected from the group consisting of an obafluorin and an obafluorin analog, wherein the obafluorin analog comprises a compound with the structure:

wherein n=0, 1, or 2; and
R=

11. The method of claim 7 , further comprising forming the beta-hydroxy-alpha-amino acid in the reaction mixture by contacting an aliphatic or aryl aldehyde or derivative thereof, an amino acid, and a pyridoxyl phosphate (PLP) cofactor with a serine hydroxymethyltransferase/threonine aldoloase, wherein:
the aliphatic or aryl aldehyde or derivative thereof is selected from the group consisting of aliphatic aldehydes, aromatic benzaldehydes, aromatic phenylacetaldehydes, and aromatic cinnamaldehydes
the amino acid is selected from the group consisting of threonine, serine, glycine, and any isomer thereof;
the serine hydroxymethyltransferase/threonine aldoloase comprises the amino acid sequence of SEQ ID NO:3; and
the reaction mixture further comprises the aliphatic or aryl aldehyde or derivative thereof, the amino acid and the serine hydroxymethyltransferase/threonine aldoloase and the pyridoxyl phosphate (PLP) cofactor.

12. The method of claim 11 , further comprising forming the aliphatic or aryl aldehyde in the reaction mixture by contacting an aliphatic or aryl pyruvate and thiamine pyrophosphate (TPP) with a thiamine dependent pyruvate decarboxylase, wherein:
the phenyl pyruvate or derivative thereof is selected from the group consisting of: p-nitrophenylpyruvate, p-hydroxyphenylpyruvate, and phenylpyruvate;
the thiamine dependent pyruvate decarboxylase comprises the amino acid sequence of SEQ ID NO:4; and
the reaction mixture further comprises the aliphatic or aryl pyruvate, the thiamine pyrophosphate (TPP), and the thiamine dependent pyruvate decarboxylase.

13. The method of claim 12 , further comprising forming the aliphatic or aryl pyruvate derivative consisting of a p-nitrophenylpyruvate derivative in the reaction mixture by contacting a p-aminophenylpyruvate derivative, oxygen, and Fe(II) with a p-aminobenzoate N-oxygenase, wherein:
the p-aminobenzoate N-oxygenase comprises the amino acid sequence of SEQ ID NO:5; and
the reaction mixture further comprises the p-nitrophenylpyruvate derivative, p-aminophenylpyruvate derivative, the oxygen

Assignees

• Wencewicz Timothy A
• Schaffer Jason E
• Reck Margaret R
• Univ Washington

Inventors

• Wencewicz Timothy A
• Schaffer Jason E
• Reck Margaret R

Classifications

• C12Y201/02001 Primary

  Glycine hydroxymethyltransferase (2.1.2.1) · CPC title

• C12M23/20

  Material Coatings (immunocoatings C12M25/00) · CPC title

• C12Y207/08007

  Holo-[acyl-carrier-protein] synthase (2.7.8.7) · CPC title

• C12P17/02 Primary

  Oxygen as only ring hetero atoms · CPC title

• C12Y401/01001

  Pyruvate decarboxylase (4.1.1.1) · CPC title